Nuvation Bio Inc. (NUVB)

Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $1.77 billion. The enterprise value is $1.28 billion.

Market Cap	1.77B
Enterprise Value	1.28B

Important Dates

The last earnings date was Monday, November 3, 2025, after market close.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Nuvation Bio has 342.76 million shares outstanding. The number of shares has increased by 42.08% in one year.

Current Share Class	341.76M
Shares Outstanding	342.76M
Shares Change (YoY)	+42.08%
Shares Change (QoQ)	+0.48%
Owned by Insiders (%)	24.88%
Owned by Institutions (%)	58.46%
Float	231.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	65.68
Forward PS	24.89
PB Ratio	5.44
P/TBV Ratio	5.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	47.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.48, with a Debt / Equity ratio of 0.18.

Current Ratio	8.48
Quick Ratio	8.26
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-32.82

Financial Efficiency

Return on equity (ROE) is -52.49% and return on invested capital (ROIC) is -32.45%.

Return on Equity (ROE)	-52.49%
Return on Assets (ROA)	-24.82%
Return on Invested Capital (ROIC)	-32.45%
Return on Capital Employed (ROCE)	-43.67%
Revenue Per Employee	$121,582
Profits Per Employee	-$988,545
Employee Count	220
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +124.78% in the last 52 weeks. The beta is 1.64, so Nuvation Bio's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	+124.78%
50-Day Moving Average	3.68
200-Day Moving Average	2.56
Relative Strength Index (RSI)	72.13
Average Volume (20 Days)	8,559,783

Short Selling Information

The latest short interest is 79.21 million, so 23.11% of the outstanding shares have been sold short.

Short Interest	79.21M
Short Previous Month	68.02M
Short % of Shares Out	23.11%
Short % of Float	34.28%
Short Ratio (days to cover)	11.71

Income Statement

In the last 12 months, Nuvation Bio had revenue of $26.75 million and -$217.48 million in losses. Loss per share was -$0.64.

Revenue	26.75M
Gross Profit	14.51M
Operating Income	-232.97M
Pretax Income	-217.48M
Net Income	-217.48M
EBITDA	-231.68M
EBIT	-232.97M
Loss Per Share	-$0.64

Balance Sheet

The company has $549.05 million in cash and $57.55 million in debt, giving a net cash position of $491.50 million or $1.43 per share.

Cash & Cash Equivalents	549.05M
Total Debt	57.55M
Net Cash	491.50M
Net Cash Per Share	$1.43
Equity (Book Value)	325.88M
Book Value Per Share	0.95
Working Capital	509.40M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	54.26%
Operating Margin	-870.98%
Pretax Margin	-813.07%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.08%
Shareholder Yield	-42.08%
Earnings Yield	-12.27%
FCF Yield	n/a

Analyst Forecast

The average price target for Nuvation Bio is $8.43, which is 63.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.43
Price Target Difference	63.06%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	138.90%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2